← Back to Clinical Trials
Recruiting NCT07619274

NCT07619274 Right Ventricular Function and Respiratory Acidosis After Cardiac Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07619274
Status Recruiting
Phase —
Sponsor Laval University
Condition Respiratory Acidosis in ICU Patients
Study Type OBSERVATIONAL
Enrollment 220 participants
Start Date 2026-07-20
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Not applicable- observational study

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 220 participants in total. It began in 2026-07-20 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Right heart dysfunction remains a frequent cause of morbidity and mortality after cardiac surgery. Respiratory acidosis, particularly when accompanied by hypoxemia, plays a significant role in right heart failure, primarily by increasing right ventricular afterload through pulmonary vasoconstriction and elevated pulmonary arterial pressures. This phenomenon leads to increased right ventricular workload, causing dilation, decreased contractility, and ultimately right heart failure. The study aims to evaluate the effect of respiratory acidosis on right ventricular function after cardiac surgery.

Eligibility Criteria

Inclusion Criteria: * Previously included and complete study NCT05886413 or NCT06826794 Exclusion Criteria: * Absence of one or more of the following hemodynamic measurements: systolic or diastolic pulmonary artery pressure, central venous pressure, cardiac output * Absence of arterial blood gas on arrival to the intensive care unit

Contact & Investigator

Central Contact

Etienne Couture

✉ etienne.couture.3@ulaval.ca

📞 1-418-656-8711

Frequently Asked Questions

Who can join the NCT07619274 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Respiratory Acidosis in ICU Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07619274 currently recruiting?

Yes, NCT07619274 is actively recruiting participants. Contact the research team at etienne.couture.3@ulaval.ca for enrollment information.

Where is the NCT07619274 trial being conducted?

This trial is being conducted at Québec, Canada.

Who is sponsoring the NCT07619274 clinical trial?

NCT07619274 is sponsored by Laval University. The trial plans to enroll 220 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology